Why the study?
Enteroviruses cause a major disease burden and are routinely identified by PCR-based methods with partial sequencing, prompting the evaluation of nanopore direct RNA sequencing for fast whole-genome sequencing directly from clinical samples.
Nanopore direct RNA sequencing can correctly identify enterovirus genotypes directly from patient stool samples with high viral load.
Enables rapid enterovirus whole-genome sequencing directly from clinical samples; leaves open routine diagnostic adoption pending validation.
Enteroviruses are small RNA viruses that affect millions of people each year by causing an important burden of disease with a broad spectrum of symptoms. In routine diagnostic laboratories, those viruses are identified by PCR based methods, often combined with partial sequencing for genotyping. In this proof-of-principle study, we assessed direct RNA sequencing (DRS) using nanopore sequencing technology for fast whole-genome sequencing of viruses directly from clinical samples. Results of the approach were complemented with those obtained by sequencing the corresponding viral cDNA via Illumina MiSeq sequencing. DRS of total RNA extracted from three different enterovirus-positive stool samples produced long RNA fragments, covering between 59% to 99.6 % of the best reference genomes. The identification of the enterovirus sequences in the sample was confirmed by the short-read cDNA sequencing. Sequence identity between DRS and Illumina MiSeq enterovirus consensus sequences ranged between 94-97%. Here we show that nanopore DRS can be used to correctly identify the genotypes of enteroviruses from patient stool samples with high viral load.
No takes yet. Share an insight, caveat, or question.
Grädel et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: